Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension

NCT02036970 is registered in ClinicalTrials.gov with Biogen as lead sponsor.

NCT NCT02036970
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02036970 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Lead sponsor
Biogen
Phase
Phase 2
Overall status
Completed
Start date
May 31, 2014
Completion date
May 16, 2018
Enrollment
166 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

acute interstitial pneumonitis, cryptogenic organizing pneumonia, desquamative interstitial pneumonia, idiopathic interstitial pneumonia, idiopathic lymphoid interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, idiopathic pulmonary fibrosis, interstitial lung disease, pulmonary arterial hypertension, pulmonary hypertension, respiratory bronchiolitis associated interstitial lung disease, sarcoidosis